Composition
- Active ingredients
- CYCLOSPORINE 25MG
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- CYCLOSPORINE 100MG · CapsuleNDA050735-002 · Prescription
- CYCLOSPORINE 25MG · CapsuleNDA050735-001 · Prescription
- CYCLOSPORINE 100MG/ML · SolutionNDA050716-001 · Prescription
- CYCLOSPORINE 50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · CapsuleNDA050715-003 · Discontinued
- CYCLOSPORINE 25MG · CapsuleNDA050715-001 · Prescription
- CYCLOSPORINE 100MG · CapsuleNDA050715-002 · Prescription
- CYCLOSPORINE 25MG · CapsuleNDA050738-001 · Prescription
- CYCLOSPORINE 100MG · CapsuleNDA050738-002 · Prescription
- CYCLOSPORINE 25MG · CapsuleNDA050737-001 · Prescription
- CYCLOSPORINE 100MG · CapsuleNDA050737-002 · Prescription
- CYCLOSPORINE 100MG · CapsuleNDA050736-002 · Prescription
- CYCLOSPORINE 25MG · CapsuleThis page
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA050736.
At a glance
- Brand name
- Neoral
- Active substance
- cyclosporine
- Route
- Oral
- Dosage form
- Capsule
- Applicant
- Novartis
- Status
- Prescription
- FDA approval
- 22 May 1997
- Application
- NDA050736-001